In a move to further increase production efficiency and modernize the site, German contract development and manufacturing organization (CDMO) Rentschler Biopharma plans to construct a new buffer media station at its company headquarters in Laupheim. According to Rentschler, this is the largest single investment in the German site.
With sustainability and carbon reduction high on the global agenda, industries are under increasing pressure to meet decarbonization targets in line with the Paris Agreement. To support companies in the chemical sector in meeting this challenge, Together for Sustainability (TfS), a global sustainability initiative representing more than 50 major chemical companies, has announced the launch of its Product Carbon Footprint (PCF) Exchange solution.
Swiss contract development and manufacturing organization (CDMO) Lonza has announced a long-term extension of its collaboration with a key global biopharmaceutical partner for the manufacture of antibody-drug conjugates (ADCs) at commercial scale. The name of the partner was not disclosed.
Dutch renewables specialist Avantium has officially opened its FDCA (furandicarboxylic acid) flagship plant in Delfzijl, the Netherlands. Plans for what was said to be the world's first commercial-scale production plant for FDCA were first announced in December 2021.
In a move to promote innovation and sustainability in the materials industry, Syensqo has entered into a partnership with the Jean-Marie Lehn Foundation.
LyondellBasell (LYB) has completed its acquisition of APK in Merseburg, Germany. The company will be fully integrated and continue as part of LYB. The deal was first announced in August of this year.
US paints and coatings group PPG has reached a definitive agreement to sell 100% of its architectural coatings business in the US and Canada to investor American Industrial Partners (AIP) for $550 million.
Sanofi has entered into talks with Clayton Dubilier & Rice (CD&R), a US-based investment company, about the potential sale of a 50% controlling stake in the French drugmaker‘s consumer healthcare business, Opella.
Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.
Danish drugmaker Lundbeck has announced to acquire US company Longboard Pharmaceuticals in a deal valued at approximately $2.6 billion. Longboard, headquartered in La Jolla, California, is a clinical-stage biopharmaceutical company focused on developing novel medicines for neurological diseases.
Solvay has inaugurated its regenerative thermal oxidation (RTO) process at its US plant at Green River, Wyoming. The innovative emissions control technology, which Solvay claims is the first of its kind in the trona mining industry, is expected to help reduce greenhouse gas emissions at the plant by up to 20% annually and achieve a 4% reduction in emissions at group level by 2025.
Mestag Therapeutics, a Cambridge, UK-headquartered biotech company working on new insights into fibroblast-immune interactions, has signed a license and collaboration agreement with US drugmaker Merck & Co., known as MSD outside of North America, to identify novel targets for the development of therapies against inflammatory diseases.
Sudarshan Chemical Industries Limited (SCIL) recently announced that it has entered into a definitive agreement with the Germany-based Heubach Group, on its acquisition in a combination of an asset and share deal. Sudarshan aims to expand its global presence and pigment portfolio across 19 sites to provide customers with a top-tier product range.
In a move to progress its strategic priorities of accelerating organic growth, Honeywell announced that it plans to spin off its Advanced Materials business into an independent, US publicly traded company. The spin-off, which is expected to be tax-free to its shareholders, is likely to be completed by the end of next year or early 2026, subject to certain customary conditions.
OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group. The company has a 30-year track record and specializes in biologics, drug-device combinations, and soft gelatin capsules.
Rio Tinto announced that it will acquire Arcadium Lithium in an all-cash transaction for $5.85 per share that values Arcadium’s at approximately $6.7 billion.
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.
A.P. Moller Holding, the mother company of shipping giant Maersk, has launched Vioneo, a manufacturer of fossil-free plastic resins and intends to establish its first production complex in Antwerp, Belgium. The plant, in which Vioneo plans to invest €1,5 billion, will benefit from the region’s expertise in the chemicals industry, strong export facilities and access to renewable energy, the company said.
Evonik recently announced the groundbreaking of a significant expansion at its Charleston site in South Carolina’s Berkeley County.
Lonza has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California, USA, from Roche for $1.2 billion. The deal was announced in March of this year.
Carbon Waters recently reached a major milestone with the installation of its first production unit at its facility in Pessac.
Air Products recently completed the sale of its liquefied natural gas (LNG) process technology and equipment business to Honeywell for $1.81 billion (€1.63 billion) in cash.
On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.
Cambrex announced that Snapdragon Chemistry, a Cambrex company, has developed a new liquid-phase peptide synthesis (LPPS) technology utilizing active pharmaceutical ingredient (API) batch reactors and continuous flow.
Azelis has signed an agreement to acquire 100% of the shares of Hortimex, a specialty chemicals distributor active in the food ingredients and nutraceuticals segments serving the Polish market.
ECI Group recently announced the signing of a licensing agreement with Shaanxi Yanchang China Coal Yulin Energy & Chemical Co., Ltd. (YECC) to deliver a 150kta copolymer plant project using ECI Group’s proprietary hybrid reactor technology.
Lonza and Vertex Pharmaceuticals recently announced a commercial supply agreement for casgevy (exagamglogene autotemcel).
Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
Covestro will start the construction of a new Thermoplastic Polyurethanes (TPU) APAC Application Development (AD) Center in Guangzhou, China.
In collaboration with Shell, COAC has implemented the Smart Equipment Passport (SEP), a solution to create digital identities of equipment that can be used to exchange information with internal and external users safely and securely.
Bilfinger is broadening its presence in Egypt by securing a substantial Project Management and Consultancy (PMC) contract from Egyptian Chemical Industries (KIMA).
Ucaneo, a provider of innovative direct air capture (DAC) technologies for CO2 removal, has raised €6.75 million in seed funding including grants.
Egrobots, a start-up from Egypt, developed a solution for efficient farm monitoring and management using AI and robotics. Their innovation includes an autonomous robot, that roams around the farm, scanning the plants on a leaf-level with high resolution and an AI that analyses this data.
